Lv4
760 积分 2023-06-12 加入
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
8天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
8天前
已完结
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer
1个月前
已完结
The adenosine pathway in immuno-oncology
2个月前
已完结
MTHFD2: A significant mitochondrial metabolic enzyme and a novel target for anticancer therapy
2个月前
已完结
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?
3个月前
已关闭
TIGIT’s immuno-oncology teachings
3个月前
已完结
OA08.01 BMS-986504 in Patients With Homozygous MTAP-Deletion (Del): Clinical Results in Patients With NSCLC Enrolled in CA240-0007
4个月前
已关闭
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
4个月前
已完结
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
